WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H574927
CAS#: 69298-22-6 (sodium)
Description: T-26c disodium is an MMP13 inhibitor..
Hodoodo Cat#: H574927
Name: T-26c disodium
CAS#: 69298-22-6 (sodium)
Chemical Formula: C24H19N3Na2O6S
Exact Mass: 0.00
Molecular Weight: 523.471
Elemental Analysis: C, 55.07; H, 3.66; N, 8.03; Na, 8.78; O, 18.34; S, 6.12
Related CAS #: 69298-22-6 (sodium) 869296-13-9 (free acid),
Synonym: T-26c disodium salt; T-26c; T 26c; T26c;
IUPAC/Chemical Name: sodium 5-(((4-carboxylatobenzyl)oxy)methyl)-2-((3-methoxybenzyl)carbamoyl)-4-oxo-4H-thieno[2,3-d]pyrimidin-1-ide
InChi Key: MJSVEIMIMXVRNJ-UHFFFAOYSA-L
InChi Code: InChI=1S/C24H21N3O6S.2Na/c1-32-18-4-2-3-15(9-18)10-25-22(29)20-26-21(28)19-17(13-34-23(19)27-20)12-33-11-14-5-7-16(8-6-14)24(30)31;;/h2-9,13H,10-12H2,1H3,(H3,25,26,27,28,29,30,31);;/q;2*+1/p-2
SMILES Code: COC1=CC=CC(CNC(C2=NC(C3=C(SC=C3COCC4=CC=C(C(O[Na])=O)C=C4)N2[Na])=O)=O)=C1
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 523.47 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1. Nara et al (2014) Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1" binding site. Bioorg.Med.Chem. 22 5487 PMID: 25192810